Meet bioSeedin at BIO 2024 | June 3-6 San Diego, CA | |
From Jun 3rd to Jun 6th, bioSeedin will hold a booth (#1604) at the 2024 BIO International Convention in San Diego, CA. This year, bioSeedin is bringing 20+ high-quality assets to the convention, aiming to provide a platform for better connecting therapeutic with global partners and resources through our asset management services. Come and visit us for a 1-on-1 partnering! | |
| Projects | Indications | Phase | Territory | | GLP-1/GIP/FGF21 Fc fusion protein | T2DM, Obesity NASH | IND in Q4 2024 | Global | | GLP-1/GIP/GCG Fatty acid chain (Oral and Injection) | T2DM, Obesity | IND in Q3 2024 | Global | | Mask DAMPs recombinant protein eye drops | Dry eye disease (DED), Neuropathic corneal pain (NCP) | Phase I finished in CN; IND approval in US | Global | | High gastrointestinal distribution TRPA1 inhibitor | IBD | IND in US and CN | Global | | High liver distribution THRβ Agonist | NASH | Phase I in CN | Global | | Small Molecule Drug Relieved Cardiac Hypertrophy and Fibrosis against Heart Failure | Heart Failure | Pre-IND in 07, 2024; IND in Q4 2024 | Global | | GPCR selective agonist | Duchenne muscular dystrophy (DMD), SLE | Preclinical | Global | | Best-in-class IRAK4 degrader | Psoriasis, RA, IBD | PCC | Global | | URAT1/XO inhibitor | Gout, Hyperuricemia | Phase I in CN | Global | | Claudin18.2 CAR-T | Advanced gastric cancer, Advanced pancreatic cancer | IND Approval | Global | | EpCAM CAR-T | Advanced Gastrointestinal Cancer | IIT | Global | | B7-H3 × CD3 bsAb | Lung cancer, kidney cancer, pancreatic cancer | IND Approval in CN | Global | | NGF mAb | Cancer-related Pain | Phase IIa | Global | | Trop2 ADC | Pancreatic cancer, lung cancer, breast cancer, uterine cancer, ovarian cancer | IND | Global | | |
(part of the assets shown) | |
About BIO
The upcoming BIO 2024 International Convention is scheduled to be held in San Diego from June 3rd to June 6th, 2024. This year, the convention aims to highlight the theme of "Time for Science to Shine."
The event is expected to attract over 20,000 leaders from the biotechnology and pharmaceutical industries, creating a unique platform for networking and fostering potential partnerships. Throughout the one-week convention, attendees will have the opportunity to explore a diverse range of topics in the field of life sciences and their applications. These include groundbreaking advancements in therapeutics, the business aspects of biotechnology, regulatory and policy perspectives, human capital considerations, etc.
| |
About bioSeedin
bioSeedin is a global transaction and consultation platform that specializes in asset management and public relations services. The company offers a comprehensive range of service, including licensing in and out, co-developmental partner sourcing, project implementation, public relation management advisory, emerging market entry strategies, investment strategy, mergers and acquisitions, and capital raising. This year, returning to BIO international convention, bioSeedin is committed to accelerating the delivery of therapeutics worldwide, ultimately benefiting patients on a global scale.
| |
Event infomation
BIO Internation Convention
Date: Jun 3-6, 2024
Location: Booth #1604 San Diego Convention Center, California
| |
|
bioSeedin and PharmaDJ co-host conference
DJSeedin 2024 on May 15-16, 2024 Shanghai, China
DJSeedin brings together thought leaders from leading biotechnology and pharmaceutical companies, investors, and partners to showcase novel technologies, discuss industry challenges and foster innovation.
| |
|
Glad to have you aboard. We encourage you to reply this email directly if you have any license in or out requests.
Best regards,
The bioSeedin Team
| | |
"Connecting your promising therapeutic with our global partners and resources" | |
| | | |
